205 related articles for article (PubMed ID: 23829486)
1. Uniqueness of ductal carcinoma in situ of the breast concurrent with papilloma: implications from a detailed topographical and histopathological study of 50 cases treated by mastectomy and wide local excision.
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Shiraiwa M; Morita T; Sato Y; Hayashi T; Kato A; Iwakoshi A; Sato T
Histopathology; 2013 Sep; 63(3):407-17. PubMed ID: 23829486
[TBL] [Abstract][Full Text] [Related]
2. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
[TBL] [Abstract][Full Text] [Related]
3. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy.
Jaffer S; Nagi C; Bleiweiss IJ
Cancer; 2009 Jul; 115(13):2837-43. PubMed ID: 19402174
[TBL] [Abstract][Full Text] [Related]
4. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy.
Rizzo M; Lund MJ; Oprea G; Schniederjan M; Wood WC; Mosunjac M
Ann Surg Oncol; 2008 Apr; 15(4):1040-7. PubMed ID: 18204989
[TBL] [Abstract][Full Text] [Related]
5. Papillary lesions of the breast: To excise or observe?
Khan S; Diaz A; Archer KJ; Lehman RR; Mullins T; Cardenosa G; Bear HD
Breast J; 2018 May; 24(3):350-355. PubMed ID: 28845569
[TBL] [Abstract][Full Text] [Related]
6. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
7. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
[TBL] [Abstract][Full Text] [Related]
8. Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H; Bomeisl P; Amin AL; Marshall HN; Gilmore H; Harbhajanka A
Hum Pathol; 2022 Oct; 128():90-100. PubMed ID: 35863513
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
10. Pathology of breast papillary neoplasms: Community hospital experience.
Vdovenko AA
Ann Diagn Pathol; 2020 Dec; 49():151605. PubMed ID: 32920473
[TBL] [Abstract][Full Text] [Related]
11. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
12. Excision recommended in high-risk patients: Revisiting the diagnosis of papilloma on core biopsy in the context of patient risk.
Chen YA; Mack JA; Karamchandani DM; Zaleski MP; Xu L; Dodge DG; Chetlen AL
Breast J; 2019 Mar; 25(2):232-236. PubMed ID: 30697873
[TBL] [Abstract][Full Text] [Related]
13. Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.
Pareja F; Corben AD; Brennan SB; Murray MP; Bowser ZL; Jakate K; Sebastiano C; Morrow M; Morris EA; Brogi E
Cancer; 2016 Sep; 122(18):2819-27. PubMed ID: 27315013
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breast.
Abe E; Suzuki K; Hayashi N; Yang Y; Li CP; Uno M; Akiyama F; Yamauchi H; Nakamura S; Tsugawa K; Tsunoda H; Ohde S; Sasano H
Pathol Int; 2014 Feb; 64(2):58-66. PubMed ID: 24629173
[TBL] [Abstract][Full Text] [Related]
15. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
[TBL] [Abstract][Full Text] [Related]
16. Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study.
Genco IS; Tugertimur B; Manolas PA; Hasanovic A; Hajiyeva S
Am J Surg; 2020 Sep; 220(3):677-681. PubMed ID: 32007236
[TBL] [Abstract][Full Text] [Related]
17. Reporting the greatest linear extent of ductal carcinoma in situ on needle core biopsy.
Reisenbichler ES; Hameed O
Hum Pathol; 2016 Apr; 50():140-5. PubMed ID: 26997448
[TBL] [Abstract][Full Text] [Related]
18. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
[TBL] [Abstract][Full Text] [Related]
19. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
20. Intraductal biopsy for diagnosis and treatment of intraductal lesions of the breast.
Matsunaga T; Kawakami Y; Namba K; Fujii M
Cancer; 2004 Nov; 101(10):2164-9. PubMed ID: 15484220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]